Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

Clinical trial NCT06558604 · RECRUITING

Trial details

NCT number: NCT06558604
Sponsor: The Lymphoma Academic Research Organisation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Mantle-Cell

Start date: 2025-02-21
Primary completion: 2028-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.